BD (NYSE: BDX) announced today that EVP and CFO Chris DelOrefice plans to depart the company to pursue a new professional ...
Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque interim CFO.
Zacks Investment Research on MSN
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
Becton, Dickinson and Company BDX, popularly known as BD, announced a multi-year collaboration with Opentrons Labworks, Inc.
BD (Becton, Dickinson and Company) announced the enrollment of the first patient in the XTRACT registry, which is designed to ...
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
News-Medical.Net on MSN
BD and Opentrons collaborate to accelerate single-cell multiomics discoveries with robotic automation
BD (Becton, Dickinson and Company), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems ...
BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through a transaction valued at $17.5 billion that ranks it as one of the largest ...
The scientific-instrument company Waters will deepen its biological sciences footprint by merging with the biosciences and diagnostic solution business of Becton, Dickinson (BD). The companies value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback